In this work, the integration of the desirable hyperbolic microfluidic chip with chemiluminescence as a signal readout enabled achieving the point-of-care testing of PCT in clinical diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
Yin et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: